Moderna
MRNA
#440
Rank
A$80.54 B
Marketcap
A$201.75
Share price
-2.23%
Change (1 day)
436.10%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$80.54 Billion

As of September 2026 Moderna has a market cap of A$80.54 Billion. This makes Moderna the world's 440th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026A$80.54 B342.53%
2025A$18.20 B-26.69%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Sep 7th, 2026 the market cap of Moderna was reported to be:

A$80.54 Billion
by Nasdaq info icon info icon
A$80.54 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$919.36 B 1,041.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$421.50 B 423.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$514.09 B 538.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
A$0.78 B-99.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.12 B-94.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A$1.15 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$49.35 B-38.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$16.90 B-79.01%๐Ÿ‡บ๐Ÿ‡ธ USA